跳至主要内容
临床试验/IRCT201207301157N7
IRCT201207301157N7已完成3 期

Efficacy of Nigella sativa L. seed oil in treatment of type 2 diabetic patients: a placebo-controlled clinical trial

Vice chancellor for research, Institute of Medicinal Plants0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
34 years 至 63 years(—)
性别
All

入选标准

  • Type 2 diabetic patients with fasting blood glucose levels between 140 and 180 mg/dl; body weight between 55 and 75 kg; age between 34 and 63 years; disease duration of 2 to 8 years; taking no more than two 500 mg metformin and two 5 mg glyburide tablets every day.
  • Exclusion criteria: Patients receiving insulin therapy; patients with cardiac, renal, hepatic and hematological diseases; patients with a history of gallstones or gall bladder surgery; patients using estrogen, steroid, beta-blocker and thiazide drugs; pregnant and breast-feeding women; alcohol consuming and cigarette smoking patients.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for research, Institute of Medicinal Plants

相似试验